BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22664831)

  • 1. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates.
    Hamada A; Yamakado K; Nakatsuka A; Uraki J; Kashima M; Takaki H; Yamanaka T; Inoue Y; Kusunoki M; Takeda K
    Jpn J Radiol; 2012 Aug; 30(7):567-74. PubMed ID: 22664831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.
    Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.
    Veltri A; Guarnieri T; Gazzera C; Busso M; Solitro F; Fora G; Racca P
    Radiol Med; 2012 Oct; 117(7):1139-51. PubMed ID: 22430677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
    Gillams AR; Lees WR
    J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
    Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
    Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
    Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
    Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
    Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
    J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiofrequency ablation of colorectal liver metastases].
    Frich L; Brabrand K; Aaløkken TM; Edwin B; Gladhaug IP
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):57-60. PubMed ID: 18183060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study.
    Berber E; Pelley R; Siperstein AE
    J Clin Oncol; 2005 Mar; 23(7):1358-64. PubMed ID: 15684312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
    Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
    Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.
    Hur H; Ko YT; Min BS; Kim KS; Choi JS; Sohn SK; Cho CH; Ko HK; Lee JT; Kim NK
    Am J Surg; 2009 Jun; 197(6):728-36. PubMed ID: 18789428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
    Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
    Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors.
    Liu L; Wang B; Zhang ZY; Wang S; Wu H; Wang H; Wu W; Yan K; Yang W
    Int J Hyperthermia; 2024; 41(1):2292950. PubMed ID: 38159558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.